From physiology to neuroendocrinology: A reappraisal of risk factors of body weight gain in humans

Diabetes and Metabolism

Volumn 24, Issue 2, 1998, Pages 108-115

  Tataranni, P A ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Body weight gain; Leptin; Obesity; Regulation; Risk factors; Sympathetic nervous system

Indexed keywords

LEPTIN;

ADRENERGIC SYSTEM; ENERGY EXPENDITURE; HUMAN; LIPID OXIDATION; OBESITY; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; WEIGHT GAIN;

BASAL METABOLISM; ENERGY METABOLISM; HUMANS; LEPTIN; NEUROSECRETORY SYSTEMS; OBESITY; PROTEINS; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; WEIGHT GAIN;

EID: 0031840497     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Kuczmarsky RJ, Fegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Survey 1960 to 1991. JAMA, 1994, 272, 205-11.
2. Ravussin E, Swimburn BA. Energy metabolism. In :. Stunkard AJ, Wadden TA, eds. "Obesity: Theory and Therapy". New York : Raven Press, 1992, 97-123.
3. Colditz GA. Economic cost of obesity. Am J Clin Nutr, 1992, 55, 503S-507S.
4. Lichtman SW, Pisarska K, Berman ER, et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med, 1992, 327, 1893-1897.
5. Ravussin E, Lillioja S, Anderson TE, Christin L, Bogardus C. Determinants of 24-hour energy expenditure in man. J Clin Invest, 1986, 78, 1568-1578.
6. Schoeller DA, Field CR. Human energy metabolism, what have we learned from the doubly labeled water method ? Ann Rev Nutr, 1991, 11, 355-373.
7. Ravussin E. Obesity in Britain : rising trend may be due to "pathoenvironment". Lancet, 1995, 311, 1569.
8. Curb JD, Marcus EB. Body fat and obesity in Japanese Americans. Am J Clin Nutr, 1991, 53, 1552S-1555S.
9. Stunkard AJ, Sorensen TIA, Hanis C, et al. An adoption study of human obesity. New Engl J Med, 1986, 314, 193-198.
10. Bouchard C, Tremblay A, Despres JP, et al. The response to long-term overfeeding in identical twins. New Engl J Med, 1990, 322, 1477-1482.
11. Stunkard AJ, Harris JR, Pederson NL, McClearn GE. Body mass index of twins who have been reared apart. New Engl J Med, 1990, 332, 1483-1487.
12. Knowler WC, Pettitt DJ, Saad MF, et al. Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr. 1991, 53, 1543S-1551S.
13. Taylor R, Badcock J, King H, et al. Dietary intake, exercise, obesity and noncommunicable disease in rural and urban populations of three Pacific Island countries. Am J Clin Nutr, 1992, 11, 283-293.
14. Ravussin E, Tataranni PA. The role of the sympathetic nervous system activity in the pathogenesis of obesity. Proc Nutr Soc, 1996, 55, 793-802.
15. Rosembaum M, Leibel RL, Hirsh J. Obesity. New Engl J Med, 1997, 337, 396-407.
16. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. New Engl J Med, 1993, 329, 1988-1892.
17. Ravussin E, Swinburn BA. Metabolic predictors of obesity. Cross-sectional versus longitudinal data. Int J Obes, 1993, 17, S28-S31.
18. Bogardus C, Lillioja S, Ravussin E, et al. Familial dependence of resting metabolic rate. New Engl J Med, 1986, 315, 96-100.
19. Tataranni PA, Ravussin E. Variability in metabolic rate : biological sites of regulation. Int J Obesity, 1995, 19, S101-S106.
20. Ravussin E, Lillioja S, Knowler WC, et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. New Engl J Med, 1988, 318, 467-472.
21. Roberts SB, Savage J, Coward WA, Chew B, Lucas A. Energy expenditure and intake in infants born to lean and overweight mothers. New Engl J Med, 1988, 318, 461-466.
22. Griffiths M, Payne PR, Stunkard AJ, Rivers JPW, Cox M. Metabolic rate and physical development in children at risk for obesity. Lancet, 1990, 336, 76-78.
23. Zurlo F, Ferraro RT, Fontvieille AM, Rising R, Bogardus C, Ravussin E. Spontaneous physical activity and obesity : cross-sectional and longitudinal studies in Pima Indians. Am J Physiol, 1992, 263, E296-E300.
24. Zurlo F, Lillioja S, Esposito-Del Puente A, et al. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol, 1990, 259, E650-E657.
25. Eckel RH. Lipoprotein lipase : a multi-functional enzyme relevant to common metabolic disorders. New Engl J Med, 1989, 320, 1060-1068.
26. Andres R, Cader G, Zierler KL. The quantitatively minor role of tightly carbohydrates in the oxidative metabolism by skeletal muscle in intact man in the basal state. Measurements of oxygen and glucose uptake and carbon dioxide and lactate production from the forearm. J Clin Invest, 1963, 35, 671-682.
27. Borensztain J. Heart and skeletal muscle lipoprotein lipase. In : Borensztain J (ed). "Lipoprotein Lipase". Chicago: Evener, 1987, 133-48.
28. Ferraro RT, Eckel RH, Larson DE, Fontvieille AM, Rising R, Jensen DR, Ravussin E. Relationship between skeletal muscle lipoprotein lipase activity and 24-hour macronutrient oxidation. J Clin Invest, 1993, 92, 441-445.
29. Zurlo F, Patti NM, Choksi RM, Sesodia S, Ravussin E. Whole-body energy metabolism and skeletal muscle biochemical characteristics. Metabolism, 1994, 43, 481-486.
30. Asish KS, Kurowski TG, Ruderman NB. A malonyl-CoA fuel-sensing mechanism in muscle : effects of insulin, glucose, and denervation. Am J Physol, 1995, 269, E283-E289.
31. Prentki M, Corkey BE. Are the β-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM ? Diabetes, 1996, 45, 273-83.
32. Niijima A, Rohner-Jenrenaud R, Jenrenaud B. Role of ventrohypothalamus on sympathetic efferent of brown adipose tissue. Am J Physiol, 1984, 247, R650-R654.
33. Sakaguchi T, Bray GA. The effect of intrahypothalamic of injections of glucose on sympathetic efferent firing rate. Brain Res Bull, 1987, 18, 591-595.
34. Knehans AW, Romsos DR. Norepinephrine turnover in obese (ob/ob) mice - effects of age, fasting and acute cold. Am J Physiol, 1983, 244, E567-E574.
35. Levin BE, Triscari J, Sullivan AC. Relationship between sympathetic activity and diet-induced obesity in two rat stains. Am J Physiol, 1983, 245, R347-R371.
36. MacDonald IA. Advances in our understanding of the role of the sympathetic nervous system in obesity. Int J Obesity, 1995, 19, S2-S7.
37. Young JB, Landsberg L. Stimulation of the sympathetic nervous system during sucrose feeding. Nature, 1977, 209, 615-617.
38. Peterson HR, Rothschild M, Weinberg C, Fell RD, Mc Leish KR, Pfeifer MA. Body fat and the activity of the sympathetic nervous system. New Engl J Med, 1988, 318, 1077-1083.
39. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest, 1993, 92, 1730-1735.
40. Sherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994, 89, 2634-2640.
41. Jones PP, Spraul M, Matt KS, Seals DR, Skinner JS, Ravussin R. Gender does not influence sympathetic neural reactivity to stress in healthy humans. Am J Physiol, 1996, 270, E363-E366.
42. Tataranni PA, Young JB, Bogardus C, Ravussin E. A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men. Obesity Research, 1997, 5, 341-347.
43. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature, 1994, 372, 424-432.
44. Pelleymounter MA, Cullen MJ, et al. Effects of the obese gene product on body weight reduction in ob/ob mice. Science, 1995, 269, 540-543.
45. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science, 1995, 269, 543-546.
46. Campfield LA, Smith FJ, Guisez Y, DeVos R, Bum P. Recombinant mouse OB protein : Evidence for a peripheral signal linking adiposity and central neural networks. Science, 1995, 269, 546-549.
47. Hamilton B. A new role for a fat actor. Nature Med, 1996, 3, 272-273.
48. Tataranni PA, Monroe MB, Dueck CA, et al. Adiposity, plasma leptin concentration and reproductive function in active and sedentary females. Int J Obesity, 1997, 21, 818-821.
49. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor OB-R. Cell, 1995, 83, 1263-1271.
50. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentration in normal-weight and obese humans. N Engl J Med, 1996, 334, 292-295.
51. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent : measurement of plasma leptin levels and ob RNA in obese and weight reduced subjects. Nature Med, 1995, 1, 1155-1161.
52. Kolaczynski JW, Nyce MR, Considine RV, et al. Acute and chronic effect of insulin on leptin production in humans. Diabetes, 1996, 45, 699-701.
53. Tataranni PA, Pratley RE, Maffei M, Ravussin E. Acute and prolonged administration of glucocorticoids (methylprednisolone) does not affect plasma leptin concentration in humans. Int J Obesity, 1997, 21, 327-330.
54. Montague CT, Sadaf Farooqi I, Whitehead PJ, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature, 1997, 387, 903-908.
55. Considine RV, Considine EL, Williams CJ, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest, 1995, 95, 2986-2988.
56. Maffei M, Stoffel M, Barone M, et al. Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes, 1996, 46, 679-682.
57. Ravussin E, Pratley RE, Maffei M, et al. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nature Med, 1997, 2, 238-240.
58. Tataranni PA, Mingrone G, Cizza G, et al. Relatively low leptin plasma concentration in post-obese women: a possible cause for relapse of body weight. IDF, 1997 [Abstract].
59. Saad MF, Alger SA, Zurlo F, Young JB, Bogardus C, Ravussin E. Ethnic difference in sympathetic nervous system mediated energy expenditure. Am J Physiol, 1991, 261, E789-E794.
60. Poehlman ET, Gardner AW, Goran MI, et al. Sympathetic nervous system activity, body fatness, and body fat distribution in younger and older males. J Appl Physiol, 1995, 78, 802-806.
61. Christin L, O'Connel M, Bogardus E,C, Danforth E, Ravussin E. Norepinephrine turnover and energy expenditure in Pima Indians and White Men. Metabolism, 1991, 42, 723-729.
62. Snitker S, Tataranni PA, Ravussin E. High sympathetic nervous system activity is associated with a high fat/carbohydrate oxidation ratio in Caucasian men, but not in Pima Indian men. NAASO, 1997 [abstract].
63. Salbe AD, Nicolson M, Ravussin E. Total energy expenditure and the level of physical activity correlate with plasma leptin concentration in 5-y old children. J Clin Invest, 1997, 99, 592-595.
64. Niskanen L, Haffner S, Karhunen LJ, Turpeinen AK, Miettinen H, Uusitupa MIJ. Serum leptin in relation to resting energy expenditure and fuel metabolism in obese subjects. Int J Obesity, 1997, 309-313.
65. Tataranni PA, Pratley RE, Nicolson M, Ravussin E. Twenty-four-hour respiratory quotient is negatively correlated with plasma leptin concentration in male Pima Indians. IDF, 1997 [abstract].
66. Shimabukuru M, Kazunori K, Chen G, et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA, 1997, 94, 4637-4641.
67. Collins et al. Leptin stimulates sympathetic outflow to brown adipose tissue. Nature, 1996, 380, 677-
68. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic activity by leptin. J Clin Invest, 1997, 100, 270-278.
69. Snitker S, Pratley RE, Nicolson M, Tataranni PA, Ravussin E. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes Res, 1997, 5, 338-340.
70. Kosaki A, Yamada K, Kuzuya H. Reduced expression of the leptin (ob) gene by catecholamine through Gs protein-coupled pathway in 3T3-L1 adipocytes. Diabetes, 1996, 45, 22A.
71. Mantzoros CS, Qu D, Frederich RC, et al. Activation of J3 adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes, 1996, 45, 909-914.